
About Kangaiweishi
Kangaiweishi was a Healthcare company based in Beijing (China) founded in 2014. It provides community resources and post-treatment tools for cancer patients. It operates on a B2C model. Kangaiweishi has raised $2 million across 2 funding rounds from investors including SoftBank. The company is recorded as dissolved. Its focus areas include Patient Support, Cancer Care and Community Tools.
Company details
Kangaiweishi, backed by 2000000.0 from SoftBank Capital, focuses on providing healthcare solutions, patient support, cancer care, and community tools. Provides community resources and post-treatment tools for cancer patients. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Beijing, China
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website kangaiweishi.com
- Social X Facebook
- Total Equity Funding$2M (USD)
in 2 rounds
- Investors
Funding Insights of Kangaiweishi
Kangaiweishi has successfully raised a total of $2M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2M
- Total Rounds 2
- First Round $2M
(Nov 2014)
- Investors Count 1
All 2 funding rounds of Kangaiweishi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2015 | Series B | β | β | β | |
| Nov 2014 | $2M | Series A | β | β |
1 investors in total: 1 institutional.
Investors in Kangaiweishi
Kangaiweishi has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SoftBank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE and VC fund focused on fintech, Adtech, gaming, eCommerce, and multiple sectors | softbank.com | Newton, United States |
Investor details for Kangaiweishi
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Kangaiweishi
3 dated milestones of Kangaiweishi across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Kangaiweishi is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series B,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kangaiweishi
Kangaiweishi was founded in 2014.
Kangaiweishi is headquartered in Beijing, China.
Kangaiweishi is a funded company, having raised a total of $2M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Nov 2014.
Kangaiweishi, backed by 2000000.0 from SoftBank Capital, focuses on providing healthcare solutions, patient support, cancer care, and community tools. Provides community resources and post-treatment tools for cancer patients. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
Kangaiweishi has 1 investor. Key investors include SoftBank.